TREATMENT WITH EVEROLIMUS LEADS TO CMV-PROTECTION DUE TO INCREASED POTENCY OF CMV-SPECIFIC CD4+T CELLS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS COMPARED TO A STANDARD REGIMEN: 12 MONTHS DATA OF THE ATHENA STUDY

Martina Sester, Stefanie Marx,Claudia Sommerer,Barbara Suwelack,Duska Dragun, Oliver Witzke,Frank Lehner,Irena Kroeger,Martina Junge, Friedrich Thaiss, Bjoern Nashan,Ingeborg A. Hauser

TRANSPLANT INTERNATIONAL(2019)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要